Bioprinting Stocks: 3D Systems and Desktop Metal
In the 3D printing world, 2021 is shaping up to be the year of bioprinting, with both 3D Systems (NYSE: DDD) and Desktop Metal (NYSE: DM) entering the commercial bioprinting market this year.
Bioprinting refers to using "bioinks" made of various biocompatible materials (some of which contain human or animal cells) to print three-dimensional, functional tissue. Current and potential future applications of the rapidly developing technology include accelerating the drug discovery process, producing body parts such as bones and soft tissue, and -- the ultimate goal -- producing solid organs for human transplantation.
Of course, neither 3D Systems nor Desktop Metal is anywhere close to a pure play on bioprinting, but they're in the market now, and that could prove to be a very good thing for their future performance.
Source Fool.com
